Home
1
News
2
Exhibition
3
2021.06.28 Manysamrt’s research appeared on Scientific Report on June, 2021.4
Missing parameters [image]

The newest publication supported by Manysmart, The potential of adoptive transfer of γ9δ2 T cells to enhance blinatumomab’s antitumor activity against B-cell malignancy, now comes to Scientific Reports. 

It strongly suggested human γ9δ2 T cells combined with CD19BiTE may provide an efficient therapy for CD19-positive B-cell cancers.

In other words, the technology of γ9δ2 T cell expansion from Manysmart fully fits the requirement of experiments and tests and the expanded γ9δ2 T cells still show a valuable anti-tumor property. 

7243822f84b07c8963ffa7d92ea8aec8.png

If you are interested in this research, please visit here.

Back to List Next